Facet Biotech

Showing 1 posts of 1 posts found.

Abbott boosts pipeline with biotech acquisition

March 10, 2010
Research and Development, Sales and Marketing Abbott, Facet Biotech, daclizumab, volociximab

Abbott is to acquire US company Facet Biotech in a $450 million deal that will boost its oncology and immunology …

The Gateway to Local Adoption Series

Latest content